Studies have shown that mutations in the gene encoding CASPR2 lead to focal epilepsy, mental retardation, schizophrenia, and other neuropsychiatric problems (Friedman et al., 2008; Saint‐Martin et al., 2018; Strauss et al., 2006). Here, CNTNAP2 is linked to schizophrenia.